ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue® from DORC (Dutch Ophthalmic Research Center (International) B.V.) has ...

ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue® from DORC (Dutch Ophthalmic Research Center ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8718 ...

Zeiss has introduced a new artificial intelligence (AI) guided image assessment tool for the Cirrus optical coherence tomography (OCT) device. At 100% Optical (1–3 March), the company demonstrated the ...

The Asia-Pacific ophthalmic diagnostic devices market was valued at $1,553.80 million in 2019 and is projected to reach $2,182.83 million by 2027, registering a CAGR of 4.3% from 2020 to 2027.

In this activity, leading experts will review innovations in retinal imaging, evaluate emerging gene and cell therapies, and assess advances in treatment protocols. This program provides an ...

MMD can lead to other eye issues, such as retinal detachment. Detecting it early can help prevent irreversible vision loss. It can lead to legal blindness if left untreated. MMD occurs when your ...

The approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) as the first and only FDA-approved treatment for macular telangiectasia type 2 (MacTel) marks a significant milestone ...

Retinal genomic DNA (gDNA) was digested with MseI ... Confocal images were acquired using SP8 Leica 2-photon confocal microscope or a Zeiss LSM 800 point scanning confocal microscope using the ...

Background Cardiovascular disease is a leading cause of global death. Prospective population-based studies have found that changes in retinal microvasculature are associated with the development of ...